QA: International Stem Cell CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001355790_2023_International_Stem_Cell_CORP.pdf

Logs

Graph

Absolute values for 0001355790, International Stem Cell CORP

  xvar xval
0 AssetsCurrent 2,963,000
1 IntangibleAssetsNetIncludingGoodwill 878,000
2 PropertyPlantAndEquipmentNet 248,000
3 remainder_Assets 1,046,000
4 LiabilitiesCurrent 4,635,000
5 LiabilitiesNoncurrent 720,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 3,269,000
8 SellingGeneralAndAdministrativeExpense 3,357,000
9 ResearchAndDevelopmentExpense 492,000
10 remainder_Expenses 1,245,000
11 remainder_Revenues 8,180,000
12 remainder_NetIncome -148,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,135,000
1 Liabilities 5,355,000
2 Expenses 8,363,000
3 Revenues 8,180,000
4 StockholdersEquity -220,000
5 NetIncome -331,000
6 ComprehensiveNetIncome -331,000
7 BaseVar 13,590,500
8 EconomicCapitalRatio -0.135

Edgar->Model Mapping

Feature Distribution

Change over Time